Furthermore, this finding was recently replicated in a study that used a fully murine CD3 redirection antibody that had relatively low level of in vitro cytotoxicity, yet exhibited significant in vivo efficacy.(17) In fact, strong activation of CD8 T cells may cause adverse events, such as cytokine release syndrome (CRS). Here, CD8A is linked to congenital rubella syndrome.